High PRR11 expression may increase the risk of transformation from non‐muscle‐invasive bladder cancer (NMIBC) to muscle‐invasive bladder cancer (MIBC), further driving the invasive and metastatic behavior of the tumor [44]. This evidence concerns the gene PRR11 and neoplasm.